MARKET OUTLOOK
An analysis by Triton Market Research concludes that the pulse oximeter market in Latin America is likely to proliferate at a CAGR of 6.14% in the forecasted period 2019-2028.
Brazil, Mexico and Rest of Latin America together form the pulse oximeter market in Latin America.
Due to poor economic conditions and the absence of a defined regulatory system, Latin America is still in its developing phase. However, the rising prevalence of target diseases is expected to attract the government’s attention, particularly in newborn screening for coronary heart disease. The region is expected to have a lucrative potential for the pulse oximeter market in the projected period.
https://www.tritonmarketresearch.com/reports/latin-america-pulse-oximeter-market#request-free-sample
A considerable proportion of the Brazilian population suffers from COPD (chronic obstructive pulmonary disease). Besides, peripheral artery disease is one of the leading causes of atherosclerotic cardiovascular morbidity. Other factors like, diabetes, hypertension, dyslipidemia, obesity and smoking are also associated with a higher occurrence of many other ailments in the region. These factors are likely to fuel the demand for pulse oximeter in the market.
The GARD (Global Alliance against Chronic Respiratory Diseases) is a network of national and global organizations, agencies and institutions, led by the WHO (World Health Organization). Following the successful global launch in China, GARD was formed in Brazil in 2006. This has helped in increasing public awareness regarding chronic respiratory diseases, and scaled up the required resources like pulse oximeter in the country.
COMPETITIVE OUTLOOK
Some of the major players in the pulse oximeter market are GE Healthcare (General Electric Company), Smiths Medical Group Limited, Zensorium, Cas Medical Systems Inc (Acquired by Edwards Lifesciences), Opto Circuits Limited, and Welch Allyn.